EMLonergan
Greenlighter
- Joined
- Aug 1, 2009
- Messages
- 15
If psychedelics are 5HT2a agonists, and tolerance results from 5HT2a downregulation, is it possible to cause an upregulation through chemical methods in order to eliminate tolerance? Wouldn't this also lead to increased MDMA effects, since 5HT2a also plays a role in the magic of MDMA experiences?
Do you think 5HT2a antagonists such as MDL 11,939 or Eplivanserin would do the trick? If not, is there any other possible way of causing this?
Here's the post on another forum that got me curious:
Do you think 5HT2a antagonists such as MDL 11,939 or Eplivanserin would do the trick? If not, is there any other possible way of causing this?
Here's the post on another forum that got me curious:
SWIM's research has led him to believe that it is the 5-HT2A receptors that are mainly responsible for the wonderful effects of MDMA (mostly in the cortex/prefrontal cortex of the brain). 5-HT2A binding in the cortex is known to stimulate oxytocin (love hormone) release in the hypothalumus. The 5-HT2A receptor is known for being the most difficult receptor to upregulate, as they do not upregulate with 5-HT2A antagonists consistently (only 2 known antagonists up-regulate 5-HT2A receptors, MDL 11,939 and SR 46349B/eplivanserin). Good luck finding either of those 2 chemicals.
What controls 5-HT2A regulation in the cortex may be more related to stress hormones and estrogen levels than other means. It has been proven that when an individual is under stress, cortisol is released from the adrenal cortex, binds to glucocorticoid receptors and in results in up-regulation of 5-HT2A in the cortex and down-regulation of 5-HT1A in the hippocampus, and also up-regulation of oxytocin receptors (estrogen is also known to have similar results, which is why many females are more sensitive to MDMA than men). This may explain why people with PTSD are so sensitive to MDMA's rewarding effects.
Read more: http://www.drugs-forum.com/forum/showthread.php?t=36636#ixzz1p8zhXBPk
